Jonathan Solomon

Jonathan Solomon, CEO of BiomX

Jonathan Solomon is the CEO and a board member of BiomX, a clinical-stage microbiome company developing both natural and engineered phage therapies.1346 He has held this position since October 2019.1

Some key facts about Jonathan Solomon:

• Prior to BiomX, he was a co-founder, president, and CEO of ProClara (formerly NeuroPhage), a company pioneering an approach to treating neurodegenerative diseases.5
• His total yearly compensation as CEO of BiomX is $1.12M, comprised of 36.8% salary and 63.2% bonuses, including company stock and options.1
• He directly owns 0.014% of BiomX's shares, worth $2.88K.1
• The average tenure of BiomX's management team is 4.9 years, while the board of directors' average tenure is less than a year.1

Solomon has been featured discussing BiomX's work developing natural and engineered phage cocktails to fight antimicrobial resistance, particularly in patients with cystic fibrosis.2 He has also presented BiomX's topline results in recent investor events.4